Status:
COMPLETED
Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness
Lead Sponsor:
Meir Medical Center
Collaborating Sponsors:
SpotOn Therapeutics Ltd.
Conditions:
Chronic Dizziness
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The diagnosis and management of acute vertigo and dizziness is most of the time an easy task for the general practitioner. However, following an acute vestibular disorder and very often with no any ov...
Eligibility Criteria
Inclusion
- Age: 18≤ years ≤85
- Clinical diagnosis of chronic dizziness primary or secondary to vestibular disorder.
- Stable symptoms for more than one month and less than a year.
- Ability to perform all tests (including computerized test) and interviews.
- Gave informed consent for participation in the study.
Exclusion
- Dizziness disease with fluctuating symptoms such as in active Meniere's disease or Benign Paroxysmal Positional Vertigo
- CNS disease or injuries
- Dizziness caused as a result of previous whiplash
- Any active or non-controlled disease that might cause dizziness (e.g. non-controlled diabetes, hypertension, anemia, respiratory, cardiovascular or endocrinological disorder etc.)
- Pregnant women
- Participation currently in another clinical study or enrolled in another clinical study within 30 days prior to this study.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01460121
Start Date
February 1 2012
End Date
October 1 2015
Last Update
May 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept Neurology, Meir Medical Center
Kfar Saba, Israel, 44281